A scoping review of disease‐modifying antirheumatic drug nonadherence in rheumatoid arthritis: Measurement, prevalence and implications for clinical practice
Much variability exists in the reported prevalence of nonadherence in RA, in what measures are used to assess nonadherence, how nonadherence is reported and which patient characteristics are associated with nonadherence.
Authors
- Emily Reeve (ORCID: https://orcid.org/0000-0002-1405-999X)
- Susanna Proudman (ORCID: https://orcid.org/0000-0002-3046-9884)
- Lisa M. Kalisch Ellett (ORCID: https://orcid.org/0000-0001-5063-6128)
- Abigail M. Freeman (ORCID: https://orcid.org/0000-0003-2465-0174)
- Jiun Ming Tan (ORCID: https://orcid.org/0000-0003-3660-6496)
- Michael D. Wiese (ORCID: https://orcid.org/0000-0002-3255-9242)
- Nagham Ailabouni (ORCID: https://orcid.org/0000-0002-6732-745X)
- Lauren Fraser (ORCID: https://orcid.org/0000-0002-4527-9872)
Institutions
- Royal Adelaide Hospital (AU)
- The University of Queensland (AU)
- University of South Australia (AU)
- Monash University (AU)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2025-09-21
- DOI
- https://doi.org/10.1002/bcp.70280
- Citations
- 1
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 1.52